Sanapac Co., Inc. 3/24/17
|
|
- Megan Lucas
- 5 years ago
- Views:
Transcription
1 Sanapac Co., Inc. 3/24/17 WARNING LETTER 17 PHI 07 PHILADELPHIA DISTRICT U.S. CUSTOMHOUSE 2ND AND CHESTNUT STREETS ROOM 900 PHILADELPHIA, PA TELEPHONE: VIA UNITED PARCEL SERVICE OVERNIGHT DELIVERY RETURN RECEIPT REQUESTED March 24, 2017 Mrs. Darlene Doble, President The Sanapac Company, Inc. 524 Orange Road Dallas, Pennsylvania Dear Mrs. Doble: The U.S. Food and Drug Administration (FDA) conducted an inspection of your dietary supplement facility, located at 524 Orange Road, Dallas, Pennsylvania, from November 28 29, 2016 and December 1 & 6, Based on our inspection, we found serious violations of the Current Good Manufacturing Practice (CGMP) regulation for Manufacturing, Packaging, Labeling or Holding Operations for Dietary Supplements, Title 21, Code of Federal Regulations, Part 111 (21 CFR Part 111). These violations cause your dietary supplement products to be adulterated within the meaning of section 402(g)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 342(g) (1)], in that they have been prepared, packed, or held under conditions that do not meet the CGMP regulations for dietary supplements found under 21 CFR Part /7
2 Additionally, the agency reviewed your website at the Internet address the products are drugs under section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)], because they are intended for use in the cure, mitigation, treatment, or prevention of disease. As explained further below, introducing or delivering these products for introduction into interstate commerce for such uses violates the Act. You can find the Act and its implementing regulations through links on FDA s home page at ( and has determined that you take orders there for the products Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products. The claims on your website and in your product pamphlet that accompanies your shipments, establish that Unapproved New Drugs The FDA reviewed your website at the internet address and your product pamphlet, which accompanies each shipment to customers. The claims on your website and other product labeling establish that the below products are drugs under section 201(g)(1)(B) of the Act, [21 U.S.C. 321(g)(1)(B)], in that they are intended for use in the cure, mitigation, treatment, or prevention of disease. The below is not an all inclusive list. All products Vitamin A (Beta Carotene) repair of body tissues. It helps maintain smooth, soft skin and helps protect the mucous membranes of the mouth, nose, throat and lungs, thereby reducing susceptibility to infections. Current medical research shows that foods rich in Beta Carotene may help reduce the risk of lung cancer, certain oral cancers and is known to have beneficial effects on vision. VITAMIN B 3 (NIACIN) lowering cholesterol levels It is also involved in controlling blood sugar levels VITAMIN B 12 helping to prevent anemia VITAMIN C helps heal wounds, scar tissue and fractures, builds resistance to infections, aids in the prevention and treatment of the common cold... It may decrease the risk of some cancers. Inner Man and Inner Man Gold SARSAPARILLA is an important aid for cystitis and renal colic from kidney stones. It is also used in the treatment of eczema dermatitis and psoriasis. Inner Women BLACK COHOSH It has anti inflammatory and antispasmodic actions that can be used to help treat painful periods. WILD YAM It has antispasmodic and anti inflammatory effects that may help ease menstrual pain. Inner Man Gold, Inner Man, and Rooster Kings SAW PALMETTO treating disorders of the urinary tract. It has also been employed to relieve persistent coughs. Inner Man Gold, Inner Man, and Inner Women POTASSIUM stimulates the kidneys to eliminate poisonous body wastes and assists in reducing high blood pressure. Your products are not generally recognized as safe and effective for the referenced uses and, therefore, the products are new drugs under section 201(p) of the Act [21 U.S.C. 321(p)]. New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in sections 301(d) 2/7
3 and 505(a) of the Act [21 U.S.C. 331(d), 355(a)]. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)], if the drug fails to bear adequate directions for its intended use(s). Adequate directions for use means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the Act [21 U.S.C. 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner. Your Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products are intended for treatment of one or more diseases that are not amenable to self diagnosis or treatment without the supervision of a licensed practitioner. Therefore, it is impossible to write adequate directions for a layperson to use your products safely for their intended purposes. Accordingly, these products fail to bear adequate directions for their intended use and, therefore, the Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. Adulterated Dietary Supplements 1. You failed to establish the required specifications for points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record, as required by 21 CFR Specifically, a. You failed to establish specifications for dietary supplement labels (label specifications) and for packaging that may come into contact with the dietary supplements (packaging specifications). Packaging that may come into contact with dietary supplements must be suitable for its intended use and must not be reactive or absorptive or otherwise affect the safety or quality of the dietary supplement as required by 21 CFR (d). Specifically, you have no specifications for dietary supplement labels and packaging for the labeling and packaging operations you perform for your dietary supplement products. b. You failed to establish specifications for each dietary supplement for the identity, purity, strength, and composition of the finished batch of the dietary supplement, and for limits on those types of contamination that may adulterate, or that may lead to adulteration of the finished batch of the dietary supplement to ensure the quality of the dietary supplement, as required by 21 CFR (e). Specifically, although your firm creates the formulations that your contract manufacturer manufactures on your behalf, you have no specifications for any of your dietary supplement formulations for the identity, purity, strength, and composition, or limits on those types of contamination that may adulterate, or may lead to adulteration for the finished batch of dietary supplements received from your co manufacturer. We note that your firm creates and changes formulations that (b)(4), as a co manufacturer, manufactures on your behalf. You also receive finished batches of dietary supplements that your firm packages and labels for distribution under your firm s name. To the extent that you contract with other firms to manufacture your product that your firm releases for distribution under your firm s name, your firm has an obligation to know what and how manufacturing activities are performed so that you can make decisions related to whether your dietary supplement products conform to established specifications and whether to approve and release the products for distribution. [72 Fed. Reg , (Jun. 25, 2007)]. Although a firm may contract out certain dietary supplement manufacturing operations, it cannot contract out its ultimate responsibility to ensure that the dietary supplement it places into commerce (or causes to be placed into commerce) is not adulterated for failure to comply with dietary supplement CGMP requirements[1]. In particular, the Act prohibits a person from introducing or delivering for introduction, or causing the delivery or introduction, into 3/7
4 interstate commerce a dietary supplement that is adulterated under section 402(g) for failure to comply with dietary supplement CGMP requirements (see 21 U.S.C. 342(g) and 331(a)). Thus, a firm that contracts out some or all of its operations must establish a system of production and process controls to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record (21 CFR ). The quality control personnel must ensure that the manufacturing, packaging, labeling, and holding operations ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record (21 CFR ). Further, you must have documentation of the quality control personnel review and approval for release of any packaged and labeled dietary supplement [21 CFR (h) and (b)(2)]. 2. You failed to establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision, as required by 21 CFR Specifically, during the inspection our investigator observed that that you did not have any procedures for the quality control inspection of your Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products received for repackaging and labeling at your facility. For example, there is no quality review and approval of your Procedure for Proper Operation of Pill Counter. Once you have established your quality control written procedures, you must implement them into your packaging, labeling, and holding operations, as required by 21 CFR We acknowledge your response, dated December 14, You indicate that you have developed and follow written quality control procedures, and made provisions to chart and track labels, caps, and all items related to packaging your products. However, you provided no documentation of your corrective actions and we intend to verify the adequacy of your response in a future inspection. 3. You failed to prepare a master manufacturing record which identifies specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the dietary supplement is packaged and labeled as specified in the master manufacturing record, as required by 21 CFR (b)(1). Specifically, your records for the repacking operations include the pill counter document and the labeling record. However, these records do not have the required specifications for your packaging and labeling processes. 4. Your packaging and labeling batch production records fail to meet the requirements of 21 CFR Specifically, a. You failed to prepare a batch production record every time you packaged and labeled a batch of a dietary supplement, as required by 21 CFR (a). Your Packaging Record (Procedure for Proper Operation of Pill Counter) and Labeling Record are not prepared for each unique batch of dietary supplement product that is packaged and labeled. Your packaging record and Labeling Record include various dietary supplement products and lot codes. b. Your batch production records fail to include complete information relating to the production and control of each batch that is packaged and labeled, as required by 21 CFR (b). For example, your Packaging Record (Procedure for Proper Operation of Pill Counter) and Labeling Record does not include documentation, at the time of performance, of packaging and labeling operations required by 21 CFR (k). c. Your batch production record fails to accurately follow the appropriate master manufacturing record, as required by 21 CFR (c). You provided the Procedure for Proper Operation of Pill Counter and Labeling Record as the batch record and the only document that your firm maintains to support your packaging and labeling operations. For example, you do not have a master manufacturing record that contains specific actions necessary to perform and verify points, steps, or stages in the manufacturing process to ensure that the dietary supplement is packaged and labeled as specified in the manufacturing record (see 21 CFR (h)). Your batch record must accurately follow the appropriate master manufacturing record, as required by 21 CFR (c). 4/7
5 5. You failed to follow written procedures for fulfilling the requirement for maintaining, cleaning, and sanitizing, as necessary, all equipment, utensils, and any other contact surfaces that are used to package, label, or hold components or dietary supplements, as required by 21 CFR (c). Specifically, your procedure for Proper Operation of Pill Counter states verification of procedures being performed shall be recorded; however, you did not document the cleaning of the hopper, vibrating feed screen, and glass turntable each time a different product was packaged. We acknowledge your response, dated December 14, You indicate that you have established charts for recording maintenance and cleaning procedures including your packaging area and all equipment used to distribute your products. However, you provided no documentation of your corrective actions and we intend to verify the adequacy of your response in a future inspection. 6. You failed to establish and follow written procedures for holding and distributing operations, as required by 21 CFR Specifically, during the inspection, you did not have written procedures for holding and distributing your products, Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings. We acknowledge your response, dated December 14, 2016; however, we find your response to be inadequate because you failed to address the need for written procedures for holding and distributing your dietary supplement products in your response. 7. You failed to establish written procedures for fulfilling the requirements of personnel, as required by 21 CFR Specifically, during the inspection you stated that you have no written procedures for hygienic practices or written procedures for the prevention of microbial contamination from sick or infected personnel. We acknowledge your response, dated December 14, You indicate that you have established formal procedures regarding hygienic practices, such as using hair nets, gloves, lab coats, and sanitizing hands. Additionally, you indicate that face masks are also to be worn while packaging to prevent microbial contamination and that these procedures have been posted. However, you provided no documentation of your corrective actions and we intend to verify the adequacy of your response in a future inspection. Misbranded Dietary Supplements Your dietary supplement products, Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings, are misbranded under Section 403 of the Act [21 U.S.C. 343], in that they fail to comply with the labeling requirements for dietary supplements. Your label violations include the following: 1. Your Inner Man, Inner Man Gold, and Inner Woman products are misbranded within the meaning of section 403(w) of the Act [21 U.S.C. 343(w)], in that the finished product labels fail to declare the major food allergen soy as required by section 403(w)(1) of the Act. Section 201(qq) of the Act, 21 U.S.C. 321(qq), defines a major food allergen as milk, egg, fish, Crustacean shellfish, tree nuts, wheat, peanuts, and soybeans, as well as any food ingredient that contains protein derived from one of these foods, with certain exceptions, e.g., highly refined oils derived from a major food allergen. A food is misbranded if it is not a raw agricultural commodity and it is, or it contains, an ingredient that bears or contains, a major food allergen, unless either: The word Contains, followed by the name of the food source from which the major food allergen is derived, is printed immediately after or is adjacent to the list of ingredients [section 403(w)(1)(A) of the Act, 21 U.S.C. 343(w)(1)(A)], or 5/7
6 The common or usual name of the major food allergen in the list of ingredients is followed in parentheses by the name of the food source from which the major food allergen is derived, except that the name of the food source is not required when either the common or usual name of the ingredient uses the name of the food source or the name of the food source appears elsewhere in the ingredient list (unless the name of the food source that appears elsewhere in the ingredient list appears as part of the name of an ingredient that is not a major food allergen) [section 403(w)(1)(B) of the Act, 21 U.S.C. 343(w)(1)(B)]. Specifically, your Inner Man, Inner Man Gold, and Inner Woman product is manufactured using soy lecithin, which contains soy. 2. Your Inner Man product is misbranded within the meaning of section 403(u) of the Act [21 U.S.C. 343(u)], in that it purports to contain ginseng, but the purported ginseng ingredient is not from a plant classified with the genus Panax. Section 403(u) of the Act, added by the Farm Security and Rural Investment Act of 2002 (Pub. L ), provides that the term "ginseng" may only be considered to be a common or usual name (or part thereof) for any herb or herbal ingredient derived from a plant classified within the genus Panax. Specifically, your product contains an ingredient identified as Ginseng Root (Eluethercocco). That ingredient may not be declared under a name that includes the term "ginseng" because it is not from the genus Panax. 3. Your Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products are misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(f)), in that the presentation of the nutrition information on the labeling of your products does not comply with 21 CFR For example, a. The Inner Man and Inner Man Gold product labels declare Potassium Gluconate; however, this should be written as Potassium (Potassium Gluconate). [21 CFR (d)]. b. The Inner Man and Inner Man Gold product labels declare potassium gluconate with a % Daily Value (DV); there is no established DV for this ingredient. However, there is a DV for potassium. [21 CFR and (b) (3)]. c. The Rooster Kings product label declares vitamin B 3 which is not the nomenclature specified in 21 CFR or (b)(2)(i)(B) for niacin. d. The Inner Man, Inner Man Gold, and Inner Woman product label lists a % Daily Value for potassium that is in the incorrect increment and must bear "Less than 1%" or "<1%" when the quantitative amount by weight is great enough to require that the dietary ingredient be listed, but small enough to be zero when rounded to the nearest percent. [21 CFR (b) (2)(iii)(C)]. e. The Inner Man, Inner Man Gold, and Inner Woman product labels incorrectly contain a heavy bar below the Amount per Serving and % Daily Value headings in the extended right column listing of dietary ingredients [21 CFR (e)(7)]. f. The Inner Man, Inner Man Gold, and Inner Woman product labels fail to place a heavy bar after the last (b) (2) dietary ingredient. [21 CFR (e)(6)]. 4. Your Inner Man, Inner Man Gold, and Inner Woman products are misbranded within the meaning of section 403(i)(2) of the Act [21 U.S.C. 343(i)(2)], in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR and 21 CFR For example, a. The Inner Man and Inner Man Gold labels declare the dietary ingredients kelp and the Inner Man label declares muira puama, but does not state the correct corresponding Latin binomial as noted in the reference Herbs of Commerce. 6/7
7 b. The Inner Man, Inner Man Gold, and Inner Woman labels declare the dietary ingredient kola nut and the Inner Man Gold label declares Golden Rod, but this is not a standardized common name noted in Herbs of Commerce. c. The Inner Man and Inner Woman labels declare the dietary ingredient Paba, but this is not the common or usual name for this dietary ingredient. 5. Your Rooster Kings product is misbranded within the meaning of 403(r)(2)(A) of the Act [21 U.S.C. 343 (r)(2) (A)], in that the label makes a claim stating the absence of a nutrient which is not in accordance with 21 CFR (e)(2). For example, your label claims sugar and starch free but does not indicate these dietary ingredients are not normally found in that type of product. 6. Your Inner Man Gold and Rooster Kings products are misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. 343(s)(2)(C)], in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). 7. Your Inner Man, Inner Man Gold, Inner Woman, and Rooster Kings products are misbranded within the meaning of 403(y) of the Act [21 U.S.C. 343(y)], in that the labels fail to include a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplements. This letter is not intended to be an all inclusive list of the violations that exist in connection with your products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with the Act and FDA regulations. You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations and implement lasting corrective action of these violations may result in regulatory action without further notice, including, without limitation, seizure and injunction. We offer you the following labeling comment: The product labels for your Rooster Kings products list Crosscarmellose Sodium as an ingredient. If your intent was to list Croscarmellose, the word is misspelled. Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentations. If you cannot complete corrective action within fifteen working days, state the reason for the delay and the time within which you will complete the correction. Section 743 of the Act [21 U.S.C. 379j 31] authorizes FDA to assess and collect fees to cover FDA s costs for certain activities, including reinspection related costs. A reinspection is one or more inspections conducted subsequent to an inspection that identified noncompliance materially related to a food safety requirement of the Act, specifically to determine whether compliance has been achieved. Reinspection related costs means all expenses, including administrative expenses, incurred in connection with FDA s arranging, conducting, and evaluating the results of the reinspection and assessing and collecting the reinspection fees [21 U.S.C. 379j 31(a)(2)(B)]. For a domestic facility, FDA will assess and collect fees for reinspection related costs from the responsible party for the domestic facility. The inspection noted in this letter identified noncompliance materially related to a food safety requirement of the Act. Accordingly, FDA may assess fees to cover any reinspection related costs. Your written response should be sent to Robin M. Rivers, Compliance Officer, at the address noted above. If you have any questions concerning this letter, please contact Ms. Rivers (215) /7
Reishi D. International, Inc. 2/6/18
Reishi D. International, Inc. 2/6/18 San Francisco District Office 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Via UPS Overnight February 7, 2018 Mr. Zheng Xiong Li, CEO Reishi D. International, Inc.
More informationRock Solid Nutrition, LLC 12/22/16
Rock Solid Nutrition, LLC 12/22/16 December 22, 2016 WARNING LETTER Kansas City District Office 8050 Marshall Drive - Suite 205 Lenexa, Kansas 66214-1524 913-495-5100 VIA UNITED PARCEL SERVICE OVERNIGHT
More informationBetter Health Lab, Inc 2/18/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Better Health Lab, Inc 2/18/15 Department of Health and Human Services Public Health Service Food and Drug Administration New Jersey
More informationLopez Gonzalez Santana Corporation dba Domel and dba Dermixx 8/28/17
Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx 8/28/17 Office of Human and Animal Food Operations East Division IV Compliance Branch 466 Avenida Fernández Juncos San Juan, Puerto Rico 00901-3223
More informationEden s Answers Inc. and Sprigs Life Inc. 12/14/17
Eden s Answers Inc. and Sprigs Life Inc. 12/14/17 Cincinnati District Office 6751 Steger Drive Cincinnati, OH 45237 Telephone: (513) 679-2700 FAX: (513) 679-2772 December 14, 2017 VIA UPS Overnight Delivery
More informationOptimum Bioenergy International Corp. 12/21/17
Optimum Bioenergy International Corp. 12/21/17 Office of Human and Animal Food Division 5 West 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Sent Via UPS Signature Required WARNING LETTER December 21,
More informationTSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17
TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE
More informationSan Diego Compounding Pharmacy 9/25/17
San Diego Compounding Pharmacy 9/25/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild Road Los Angeles, CA 92612 WARNING LETTER VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED September
More informationGenetic Edge Compounds LLC 4/14/17
Genetic Edge Compounds LLC 4/14/17 April 14, 2017 2017 DAL WL 15 UPS Overnight Bradley N. Howard, Owner and CEO Genetic Edge Compounds, LLC (b)(6), (b)(7)(c) McKinney, Texas 75070 Mr. Howard: WARNING LETTER
More informationTruVision Health LLC 11/30/17
TruVision Health LLC 11/30/17 Denver District Office 6 th Ave & Kipling St, Bldg 20 DFC P.O. Box 25087 Denver, CO 80225 November 30, 2017 WARNING LETTER Via UPS Overnight Ref: # HAFW4(DEN)-18-02-WL David
More informationTobin's Royal Stag, Inc. dba Tobin Farms Velvet Antler 4/19/17
Tobin's Royal Stag, Inc. dba Tobin Farms Velvet Antler 4/19/17 UNITED PARCEL SERVICE OVERNIGHT DELIVERY April 19, 2017 Darrell Tobin Owner Tobin's Royal Stag, Inc. P.O. Box 108 Alna, ME 04535 0108 Dear
More informationPick and Pay Inc dba Cili Minerals 5/8/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Pick and Pay Inc dba Cili Minerals 5/8/15 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationHieber's Pharmacy 12/5/17
Hieber's Pharmacy 12/5/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973) 331-4969 CERTIFIED MAIL RETURN RECEIPT REQUESTED
More informationStonegate Pharmacy LP 11/10/16
Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite
More informationPublic Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas
Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 March 30, 2010 2010-DAL-WL-08 CERTIFIED
More informationRed Mill Farms LLC 9/17/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Red Mill Farms LLC 9/17/15 Department of Health and Human Services Public Health Service Food and Drug Administration PHILADELPHIA
More informationTown and Country Compounding and Consultation Services, LLC 10/17/17
Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)
More informationLong Life Unlimited 1/31/18
Long Life Unlimited 1/31/18 Cincinnati District Office 6751 Steger Drive Cincinnati, OH 45237 Telephone: (513) 679-2700 FAX: (513) 679-2772 WARNING LETTER 533282 January 31, 2018 VIA UPS Long Life Unlimited,
More informationTalon Compounding Pharmacy 10/3/17
Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING
More informationOpiate Freedom Center 1/11/18
Opiate Freedom Center 1/11/18 UNITED STATES OF AMERICA DEPARTMENT OF HEALTH FEDERAL TRADE COMMISSION AND HUMAN SERVICES BUREAU OF CONSUMER FOOD AND DRUG ADMINISTRATION PROTECTION SILVER SPRING, MD 20993
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations V-SAB Medical Labs,
More informationcgmp (21 CFR 111) Regulation and Compliance Overview
cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation
More informationRaritan Pharmaceuticals, Inc. 6/20/17
Raritan Pharmaceuticals, Inc. 6/20/17 U.S. Food & Drug Administration Division of Pharmaceutical Quality Operations I New Jersey District 10 Waterview Boulevard, 3rd Floor Parsippany, NJ 07054 June 20,
More informationNYSW Beverage Brands 1/7/15
8/26/2015 2015 > NYSW Beverage Brands 1/7/15 U.S. Food and Drug Administration Protecting and Promoting Your Health NYSW Beverage Brands 1/7/15 SHARE (HTTPS://WWW.FACEBOOK.COM/SHARER/SHARER.PHP? U=HTTP%3A%2F%2FWWW.FDA.GOV%2FICECI%2FENFORCEMENTACTIONS%2FWARNINGLETTERS%2F2015%2FUCM429530.HTM)
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations P.A. Benjamin Manufacturing
More informationPublic Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/
Department of Health and Human Services Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Telephone: 510/337-6700 WARNING LETTER December
More informationOverview of Dietary Supplement GMP Inspection Trends Quality Session 6
Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,
More informationMay 12, 2017 WARNING LETTER
U.S. Food and Drug Administration Seattle District Office 22215 26th Avenue SE, Suite 210 Bothell, Washington 98021 May 12, 2017 OVERNIGHT DELIVERY SIGNATURE REQUIRED In reply refer to WL SEA 17-14 Otto
More informationAie Pharmaceuticals Inc 4/17/17
Aie Pharmaceuticals Inc 4/17/17 WARNING LETTER Los Angeles District 19701 Fairchild Road Los Angeles, CA 92612 UNITED PARCEL SERVICE SIGNATURE REQUIRED April 17, 2017 Dr. Magdi Youssef AIE Pharmaceuticals,
More informationInternational Food Systems QUALITY SERVICE INNOVATION IN FOOD INGREDIENTS
Product Specification Sheet Organic Sprouted Purple Corn Blend W/ Sprouted Grains Product No: QH 24-3 Description: Organic Sprouted Purple Corn Blend QH 24-3 is a dark colored grain blend intended for
More informationNew England Compounding Center 04-Dec-06
New England Compounding Center 04-Dec-06 Department of Health and Human Services Public Health Service Food and Drug Administration New England District One Montvale Avenue Stoneham, Massachusetts 02180
More informationFinal Rule for Preventive Controls for Animal Food
Final Rule for Preventive Controls for Animal Food http://www.fda.gov/fsma THE FUTURE IS NOW 1 Background Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations A Nelson & Co.,
More informationAKA Good Manufacturing Practice (GMP) Certification Program
AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements
More informationNestle Infant Nutrition 10/31/14
U.S. Food and Drug Administration Protecting and Promoting Your Health Nestle Infant Nutrition 10/31/14 OCT 31, 2014 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationAllergy Inspection Guide (4/01)
Allergy Inspection Guide (4/01) GUIDANCE ON INSPECTIONS OF FIRMS PRODUCING FOOD PRODUCTS SUSCEPTIBLE TO CONTAMINATION WITH ALLERGENIC INGREDIENTS This guidance is reference material for investigators and
More informationSandoz Inc. 12-Aug-08
Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL
More informationNOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852-1448 September 26, 2011 By Overnight Delivery Michael Dean Berger, M.D.
More informationSUPPLIER INGREDIENT INFORMATION. 50 lb bag
SUPPLIER INGREDIENT INFORMATION CHOLMONDLEY'S ENGLISH MUFFIN LOAF BASE BRAND: ORTH 3206354-00 Cholmondley's English Muffin Loaf Base is a pre-blended, fully prepared, dry mix base for using in bread applications.
More informationCase: 1:18-cv Document #: 1 Filed: 07/26/18 Page 1 of 19 PageID #:1 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS
Case: 1:18-cv-05104 Document #: 1 Filed: 07/26/18 Page 1 of 19 PageID #:1 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) v. ) ) Civil
More informationCERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED Esther Hernandez President United States Blood Bank, Inc. 2400 NW 95th
More informationAbsonutrix 7/25/17. Atlanta District Office 60 8th Street NE Atlanta, GA July 25, 2017 VIA UPS
Absonutrix 7/25/17 Atlanta District Office 60 8th Street NE Atlanta, GA 30309 July 25, 2017 VIA UPS Himanshu Nautiyal, Owner Absonutrix, LLC 317 S. Westgate Drive Suite J Greensboro, NC 27407 WARNING LETTER
More informationCSM Bakery Solutions 1912 Montreal Road Tucker GA
CSM Bakery Solutions 1912 Montreal Road Tucker GA 30084 770-938-3823 PRODUCT DATA SHEET www.csmbakerysolutions.com CIB 300 CHOCOLATE ICING BASE MATERIAL CODES Article number CSM article number 10179662
More informationFood Recalls: May 25, 2016 GREENBERG TRAURIG, LLP ATTORNEYS AT LAW Greenberg Traurig, LLP. All rights reserved.
Food Recalls: 2016 Greenberg Traurig, LLP. Attorneys at Law. All rights reserved. Greenberg Traurig is a trademark and trade name of Greenberg Traurig, LLP and Greenberg Traurig, P.A. This presentation
More informationAlignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference
Alignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference Donald Kautter US Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food
More informationSouthern California Section & Western Compendial Discussion Group
Association for Official and Analytical Chemists Southern California Section & Western Compendial Discussion Group October 6, 2011 Compliance Officer Bill Vitale, Food and Drug Administration Los Angeles
More informationFood Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY
Statutory Instrument 120 of 2016 Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) [Cap 15:05 Section 1 Title 2 Interpretation ARRANGEMENT OF SECTIONS PART I PRELIMINARY 3 Inspection
More informationProduct Information Sheet CLARIA Elite
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationProduct Information Sheet CLARIA Bliss
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationGuidance for Handling and Labeling
ECOCERT ICO Page 1/7 This guideline does not replace the current Regulation. It provides some explanations on main requirements for organic handling and labeling. To understand the complete organic requirements,
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 9 Inspections, Compliance, Enforcement, and Criminal Investigations Phoenix Medical Devices, LLC 9/29/2009 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f J Dallas District 4040 North Central Expressway Dallas, Texas 75204-3145 Ref: 2004-DAL-WL-03 WARNING LETTER CERTIFIED MAIL RETURN
More informationProduct Information Sheet SODA-LO EXTRA FINE IODIZED
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationTheoriginalhcgdrops.com 11/28/11
Theoriginalhcgdrops.com 11/28/11 UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION BUREAU OF CONSUMER PROTECTION WASHINGTON, D.C. 20580 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationProduct Information Sheet REZISTA DF
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More information2014 FDA/JIFSAN Food & Nutrition Webinar
2014 FDA/JIFSAN Food & Nutrition Webinar Medical Foods Shawne Suggs-Anderson, MMSc, _ RD Infant Formula and Medical Foods Staff ONLDS/CFSAN/FDA September 23, 2014 53 Main Objectives History What is a Medical
More informationFOOD LABELING 101. an ebook from ESHA Research
FOOD LABELING 101 1 an ebook from ESHA Research MOST PACKAGED FOOD ITEMS SOLD IN THE UNITED STATES ARE REGULATED BY THE FDA AND MUST DISPLAY A PRODUCT LABEL, THE RULES FOR WHICH CAN BE LONG AND COMPLICATED.
More informationProduct Information Sheet
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationProduct Information Sheet REZISTA HV
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationFDA RELEASES FOOD CURRENT GOOD MANUFACTURING PRACTICE MODERNIZATION REPORT
November 17, 2005 FDA RELEASES FOOD CURRENT GOOD MANUFACTURING PRACTICE MODERNIZATION REPORT Executive Summary On November 2, 2005, FDA issued the Food CGMP Modernization - A Focus on Food Safety report.
More informationNutrition Labeling of Single- Ingredient Products and Ground or Chopped Meat and Poultry Products
Nutrition Labeling of Single- Ingredient Products and Ground or Chopped Meat and Poultry Products 1 Summary of Provisions in the Final Rule Major Cuts: The final rule requires nutrition labeling of the
More informationSUPPLEMENTS PACKAGING 101: ELEMENTS, PLACEMENT, LABELING AND CLAIMS. an ebook from ESHA Research
SUPPLEMENTS PACKAGING 101: ELEMENTS, PLACEMENT, LABELING AND CLAIMS an ebook from ESHA Research SUPPLEMENTS PACKAGING 101 2 TABLE OF CONTENTS Introduction... 3 Definition... 4 Packaging Basics... 5 What
More informationCase: 5:15-cr DCR-REW Doc #: 1 Filed: 10/01/15 Page: 1 of 15 - Page ID#: 1
Case: 5:15-cr-00087-DCR-REW Doc #: 1 Filed: 10/01/15 Page: 1 of 15 - Page ID#: 1 UNITED STATES OF AMERICA UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY CENTRAL DIVISION LEXINGTON EastemDistr1ot
More informationApril 30, By Electronic Mail
April 30, 2018 By Electronic Mail Dr. Scott Gottlieb, Commissioner Office of the Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 CommissionerFDA@fda.hhs.gov
More informationFood Commissaries under FSMA and the US FDA model Food Code
Food Commissaries under FSMA and the US FDA model Food Code Introduction A food commissary is a facility or operation that procures and/or produces foods intended for distribution. A retail or foodservice
More informationProduct Information Sheet SODA-LO EXTRA FINE
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationProduct Information Sheet TASTEVA Stevia Sweetener
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationTeva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044
DEPARTMENT OF HEALTH & HUMAN SERVICES ANDA 090783 Food and Drug Administration Silver Spring, MD 20993 Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs
More informationRe: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.
VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;
More informationTechnical Data Sheet Product Code PR Primex Donut Fry Shortening
Technical Data Sheet Product Code - 106110 PR Primex Donut Fry Shortening Made with Golden Flex Technology Benefits and Applications: 0g trans-fat per tablespoon (12g) An all soybean formula shortening
More informationAs Introduced. 132nd General Assembly Regular Session H. B. No
132nd General Assembly Regular Session H. B. No. 560 2017-2018 Representative Lanese A B I L L To amend sections 923.41, 923.48, and 923.51 of the Revised Code to prohibit pet food from containing remains
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO ) ) ) ) ) ) ) ) ) INFORMATION. General Allegations. A. Introduction and Background
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO UNITED STATES OF AMERICA, Plaintiff, vs. MOHAMED BASEL ASWAD, M.D., Defendant. CRIMINAL NO. 21 U.S.C. 331(a and 333(a(1: Introduction
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 8 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationProduct Information Sheet
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationTaylor C. Wallace, PhD, CFS, FACN, March 22, 2018
Food Ingredients Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Disclosures Think Healthy Group, Inc. George Mason University, Department of Nutrition and Food Studies Journal of the American College
More informationAgency Information Collection Activities; Submission for Office of Management and Budget
This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationCase 2:18-cv JTF-dkv Document 1 Filed 09/25/18 Page 1 of 17 PageID 1 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TENNESSEE
Case 2:18-cv-02656-JTF-dkv Document 1 Filed 09/25/18 Page 1 of 17 PageID 1 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TENNESSEE ) UNITED STATES OF AMERICA, ) ) Civil No: 18-2656 Plaintiff,
More informationOUR COMMITMENT OPEN DIALOGUE & DEBATE COMMITMENT TO EDUCATION
Everyday we make choices and take actions that ensure the scientific-basis and quality of Nature Made vitamins and supplements. As a vitamin and supplement company, for Nature Made transparency means:
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation
More informationFDA Food Safety Modernization Act (FSMA) January 4, 2011
FDA Food Safety Modernization Act (FSMA) January 4, 2011 FDA Food Safety Modernization Act (FSMA) The Most Sweeping Reform of the U.S. Food Safety Laws in More than 70 Years FDA Food Safety Modernization
More informationResponding to a Food Recall
Responding to a Food Recall Time: 4 hours National Food Service Management Institute The University of Mississippi 2013 Table of Contents Objectives... ii Lesson 1: Introduction to the Food Recall Process...
More informationJuly 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at:
July 27-30, 2015 104 th Annual Meeting of the Poultry Science Association Louisville, Kentucky Presented at: From Egg to Plate The Influence of Gut Health Symposium Presentations distributed by DuPont
More informationForeign Supplier Verification Programs for Importers of Food for Humans and Animals
Foreign Supplier Verification Programs for Importers of Food for Humans and Animals Docket No. FDA-2011-N-0143 Reference 2: FDA, Proposed 21 Code of Federal Regulations, Part 1, Subpart L Foreign Supplier
More informationLabeling Requirements for Distribution out of a Licensed Kitchen
Tillamook County Tillamook County Health Department Our Mission... To protect and promote the health of all people in Tillamook County. Labeling Requirements for Distribution out of a Licensed Kitchen
More informationCommercial Feed Mill Verification Task Procedures
Introduction The Canadian Food Inspection Agency (CFIA) is dedicated to safeguarding food, animals and plants, which enhances the health and well-being of Canada s people, environment and economy. As part
More informationFood Safety and Inspection Service:
1 Overview and Update on Current FSIS Labeling Activities Jeff Canavan, Deputy Director Labeling and Program Delivery Staff, FSIS February 5, 2018 2 Mission in Action We are the public health agency in
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationALLERGENS. Many different foods can cause an allergic reaction, however; the majority of food allergies are caused by: Peanuts, Soybeans, Milk, Eggs,
ALLERGENS People can eat most food safely. But, imagine what it would be like if eating a peanut butter sandwich or drinking a glass of milk left you vomiting, gasping for breath, and furiously scratching
More informationLIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Food Recall Process Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement Wednesday, December 9, 2009 LEGAL ISSUES Code of Federal Regulations
More informationCALIFORNIA HOMEMADE FOOD ACT AB 1616 (GATTO) REGISTRATION / PERMITTING FORM. CFO Business Name:
LeslieLindbo,MBA,REHS DirectorofEnvironmentalHealth CALIFORNIA HOMEMADE FOOD ACT AB 1616 (GATTO) REGISTRATION / PERMITTING FORM CFO Business Name: CFO Physical Address: Owner Name: Mailing Address (if
More informationFood Allergen Environmental Monitoring Guide
Food Allergen Environmental Monitoring Guide A EUROFINS WHITE PAPER OCTOBER 2012 This document by Eurofins is licensed under a Creative Commons Attribution 3.0 Unported License. A COMPREHENSIVE GUIDE TO
More informationGuideline n 4 NOP Handling and Labeling
TS04(NOP)v05en Guideline n 4 NOP Handling and Labeling According to the USDA National Organic Program (NOP) This guideline does not replace the current Regulation. It provides some explanations on main
More informationGuidance for Industry
Guidance for Industry Dosage Delivery Devices for OTC Liquid Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationFood Safety and Inspection Service: Labeling Guideline on Documentation Needed to Substantiate Animal Raising Claims for Label Submission
Labeling Guideline on Documentation Needed to Substantiate Animal Raising Claims for Label Submission Presentation given today by: Tammie M. Ballard, Food Technologist, Animal Raising Team Leader, Labeling
More informationThe Food Safety Modernization Act A Series on What is Essential for a Food Professional to Know
SPECIAL INTEREST PAPER The Food Safety Modernization Act A Series on What is Essential for a Food Professional to Know [ Article 2. Hazard Analysis and Risk Based Preventive Controls [ Theodora Morille-Hinds*
More informationOver-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen
Reprinted from FDA s website by EAS Consulting Group, LLC Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed
More informationFSMA & The Dietary Supplements Industry
FSMA & The Dietary Supplements Industry Overview FDA Food Safety Modernization Act (FSMA) Preventive Controls for Human Food (PCHF) Foreign Supplier Verification Programs (FSVP) Produce Verification activities
More information